← Leaderboards
Weiqiang Zhang
University Of Tennessee Health Sci Ctr
$1,885,290
Attributed
$1,885,290
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $384.7K · FY2014–18$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$1,885,290 · 1
By mechanism
R01$1,885,290 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tennessee Health Sci Ctr
Same institution · by research overlap
- Anjaparavanda P Naren$16,948,975
- Gabor J Tigyi$24,190,037
- Bernd Meibohm$2,938,789
- Jur Strobos$539,515
- Lisa K Jennings$260,000
Others in their field
Top investigators on “Vx-809”
- Dean R Madden · Dartmouth College$3,123,980
- Jennifer Wambach · Washington University$2,479,112
- Agnieszka Swiatecka-Urban · Dartmouth College$2,418,848
- Gergely L. Lukacs · Hospital For Sick Chldrn (Toronto)$2,268,933
- John Robert Yates · Scripps Research Institute, The$2,146,994
- Liudmila Cebotaru · Johns Hopkins University$1,917,840
Research focus
Vx-809CellsCell SurfaceChronic Lung DiseaseClinical TrialsComplexCystic FibrosisCystic Fibrosis PatientsCystic Fibrosis Transmembrane Conductance RegulatorDefectDisease-Causing MutationEpithelial CellsExhibitsFunctional DisorderGenisteinStudy SubjectTissuesTracheal EpitheliumVx-770Cell MembraneInheritedInhibitor/AntagonistIntestinesIn Vitro
Grant awards (5)
Characterization of an inhibitory protein complex for cystic fibrosis therapy$375,696
R01 · FY2018 · HL · contact PI
Characterization of an inhibitory protein complex for cystic fibrosis therapy$375,694
R01 · FY2017 · HL · contact PI
Characterization of an inhibitory protein complex for cystic fibrosis therapy$375,696
R01 · FY2016 · HL · contact PI
Characterization of an inhibitory protein complex for cystic fibrosis therapy$373,467
R01 · FY2015 · HL · contact PI
Characterization of an inhibitory protein complex for cystic fibrosis therapy$384,737
R01 · FY2014 · HL · contact PI